Walleye Trading’s Milestone Pharmaceuticals MIST Stock Holding History

Walleye Trading’s Portfolio MIST Stock Details MIST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-12,513	Closed	-$49.3K	–	4980
2023 Q1	$49.3K	Sell	12,513 -21,452	-63%	-$78.4K	﹤0.01%	4078
2022 Q4	$135K	Buy	+33,965	New	+$179K	﹤0.01%	3821

Other funds holding MIST

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return

AFA

Alta Fundamental Advisers New York $265M AUM 98.61% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Walleye Trading's MIST Position: Q2 2023 in Review

Walleye Trading sold out of Milestone Pharmaceuticals (MIST) in Q2 2023, closing a stake of 12,513 shares — an estimated $49.3K sold.

Walleye Trading first reported a position in MIST in Q4 2022 and held it in 2 quarters. The position peaked at $135K in Q4 2022. 48 funds tracked by Wall St. Rank hold MIST as of Q2 2023.

Walleye Trading reported no remaining Milestone Pharmaceuticals position as of Q2 2023 after selling out during the quarter.
Walleye Trading sold 12,513 Milestone Pharmaceuticals shares in Q2 2023, an estimated $49.3K.
Walleye Trading first reported a position in Milestone Pharmaceuticals in Q4 2022 and held it in 2 quarters.
Walleye Trading's Milestone Pharmaceuticals position peaked at $135K in Q4 2022.
48 funds tracked by Wall St. Rank held Milestone Pharmaceuticals as of Q2 2023.

Based on Walleye Trading's 13F filing for Q2 2023, filed 14 Aug 2023.